It's true wideout "I don't have a clue what is happening behind the scenes" and that concerns me, particularly with missed deadlines and things like the last presentation.

I don't think I pretend to know what is happening behind the scenes. I don't know Don or anyone at RVX beyond following the company for the past 10 years of so.

And I'm certainly not a wise investor.   :)  lol

What I do know is that numerous Canadian biotechs have recently rewarded their shareholders handsomely over the past couple of years and that is fine. Every situation is different.

An example I've used before is Repare Therapeutics founded by 3 scientists who then brought in investors to build the company and management. The lead investment company put one of their people in to be CEO. They then brought in other investment companies and built a board full of former pharma and biotech business people and McKinsey types. Well connected throughout BP. They took the company public on NASDAQ at $20USD and sold out rapidly. This was all achieved before even one drug reached clinical trials stage. Their scientific model is drug development using SNIPRx. I've looked at Repare with the benefit of hindsight but it seemed that clarity to investors along the journey was one of their hallmarks.

RVX and Zenith have great scientific talent and achievements. Success, however, requires excellence on the business side as well.

Enough said. Ive beaten this to death and should probably join San Fran at this point      :).

I have nothing against Don. He has been exceptionally successful and well rewarded.

So best of luck to you wideout and to all of us. I'm keeping my shares because at some point something good is going to happen.

GLTA

Toinv